N-(indolcarbonyl-)piperazine derivatives

Details N-(indolcarbonyl-)piperazine derivatives N-(indolcarbonyl-)piperazine derivatives

2005-01-04

2005-01-04

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S252020, C514S252010, C514S252110, C514S252190, C514S253060, C514S253070, C514S253090, C514S254020, C514S254030, C514S254040, C514S254050, C514S254060, C544S233000, C544S238000, C544S284000, C544S295000, C544S296000, C544S360000, C544S363000, C544S367000, C544S368000, C544S369000, C544S370000, C544S371000, C544S373000

Reexamination Certificate

active

06838461

ABSTRACT:
Compounds of the formula Iin which R1, R2, R4and R5have the meanings indicated in claim1, are potent 5-HT2Aantagonists and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkingson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, eating disorders such as bulimia, nervous anorexia, premenstrual syndrome and/or for positively affecting compulsive behavior (obsessive-compulsive disorder, OCD).

REFERENCES:
patent: 5032598 (1991-07-01), Baldwin et al.
patent: 5032604 (1991-07-01), Baldwin et al.
patent: 6218394 (2001-04-01), Perregaard et al.
patent: 0 320 983 (1989-06-01), None
patent: 0 431 945 (1991-06-01), None
patent: 0 599 240 (1994-06-01), None
patent: 0320983 (1995-06-01), None
patent: P9603371 (1997-09-01), None
patent: WO 9806715 (1998-02-01), None
patent: WO 9911641 (1999-03-01), None
patent: WO 9911641 (1999-03-01), None
Robichaud et al, Annual Reports in Medicinal Chemistry, vol. 35,p. 11-20 (2000)/.

Affiliated with

Also associated with

Rating

N-(indolcarbonyl-)piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(indolcarbonyl-)piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(indolcarbonyl-)piperazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3395829